New EU Filings Include Serplulimab For Lung Cancer & Zynyz For MCC

 
• By Neena Brizmohun

EU marketing applications for eight new products have begun the regulatory review process at the European Medicines Agency.

New medicines are under regulatory review for potential EU marketing approval • Source: Shutterstock

More from Product Reviews

More from Pink Sheet